News
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
"We have a couple dozen patients who are 5, 6, 7, 9 years out or more without further therapy. That feels like a cure to me."
Rosa's experience working in the lab and participating in the PCI Fellows program at Penn helped her gain valuable experience for her career at Deloitte.
While the CGT industry is growing at a rapid rate, real estate development happens much slower, which may have implications for the amount of available space.
Regenxbio's gene therapy would eliminate the need for wet AMD patients to visit their doctor every few months to receive a needle in their eye to treat their condition.
In a proof-of-concept study, microrobots effectively cleaned plaque and decay-causing bacteria from both mock and human teeth.
A major goal of this research is to help self-driving cars and other autonomous transportation systems achieve increased efficiency and performance, as well as better safety guarantees.
Learn about these cutting-edge new projects that are improving value-based medical care.
Penn Medicine ranked number two out of the top five large health systems, second only to Mayo Clinic in Rochester, MN.
Kelly is the CEO of Carisma Therapeutics, a PCI startup that provides cellular immunotherapy for solid tumors.
Learn about Marion Leary and her mission to help health professionals pursue a career path in innovation.